Statin use and thyroid cancer: A population-based case-control study

Shih Han Hung, Herng Ching Lin, Shiu Dong Chung

研究成果: 雜誌貢獻文章

8 引文 (Scopus)

摘要

Objective Several observational studies raised the possibility that the use of statins may decrease the overall risk of cancer and of specific cancers. This study aimed to evaluate the association of statin use with thyroid cancer based on a population-based data set. Design The data for this case-control study were sourced from the Taiwan Longitudinal Health Insurance Database 2000. We included 500 subjects with thyroid cancer as cases and 2500 gender- and age-matched subjects without thyroid cancer as controls. We used a conditional logistic regression to calculate the odds ratio (OR) and its corresponding 95% confidence interval (CI) for having previously used statins between cases and controls. Results The OR of prior statin use for cases was 1·39 (95% CI = 1·08-1·78) compared to controls, and thyroid cancer was significantly associated with previous regular statin use (OR = 1·40, 95% CI = 1·05-1·86). However, thyroid cancer was not significantly associated with previous irregular statin use (OR = 1·35; 95% CI = 0·88-2·07). Furthermore, the significant association between thyroid cancer and previous statin use only existed for females (OR: 1·43; 95% CI: 1·07-1·90) but not for males (OR: 1·28; 95% CI: 0·75-2·17). Conclusions We concluded that statin use was associated with thyroid cancer in female patients.
原文英語
頁(從 - 到)111-116
頁數6
期刊Clinical Endocrinology
83
發行號1
DOIs
出版狀態已發佈 - 七月 1 2015

指紋

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Thyroid Neoplasms
Case-Control Studies
Odds Ratio
Confidence Intervals
Population
Health Insurance
Taiwan
Observational Studies
Neoplasms
Logistic Models
Databases

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

引用此文

Statin use and thyroid cancer : A population-based case-control study. / Hung, Shih Han; Lin, Herng Ching; Chung, Shiu Dong.

於: Clinical Endocrinology, 卷 83, 編號 1, 01.07.2015, p. 111-116.

研究成果: 雜誌貢獻文章

@article{d1a067c37acf4570a8419803d0b1ea55,
title = "Statin use and thyroid cancer: A population-based case-control study",
abstract = "Objective Several observational studies raised the possibility that the use of statins may decrease the overall risk of cancer and of specific cancers. This study aimed to evaluate the association of statin use with thyroid cancer based on a population-based data set. Design The data for this case-control study were sourced from the Taiwan Longitudinal Health Insurance Database 2000. We included 500 subjects with thyroid cancer as cases and 2500 gender- and age-matched subjects without thyroid cancer as controls. We used a conditional logistic regression to calculate the odds ratio (OR) and its corresponding 95{\%} confidence interval (CI) for having previously used statins between cases and controls. Results The OR of prior statin use for cases was 1·39 (95{\%} CI = 1·08-1·78) compared to controls, and thyroid cancer was significantly associated with previous regular statin use (OR = 1·40, 95{\%} CI = 1·05-1·86). However, thyroid cancer was not significantly associated with previous irregular statin use (OR = 1·35; 95{\%} CI = 0·88-2·07). Furthermore, the significant association between thyroid cancer and previous statin use only existed for females (OR: 1·43; 95{\%} CI: 1·07-1·90) but not for males (OR: 1·28; 95{\%} CI: 0·75-2·17). Conclusions We concluded that statin use was associated with thyroid cancer in female patients.",
author = "Hung, {Shih Han} and Lin, {Herng Ching} and Chung, {Shiu Dong}",
year = "2015",
month = "7",
day = "1",
doi = "10.1111/cen.12570",
language = "English",
volume = "83",
pages = "111--116",
journal = "Clinical Endocrinology",
issn = "0300-0664",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Statin use and thyroid cancer

T2 - A population-based case-control study

AU - Hung, Shih Han

AU - Lin, Herng Ching

AU - Chung, Shiu Dong

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Objective Several observational studies raised the possibility that the use of statins may decrease the overall risk of cancer and of specific cancers. This study aimed to evaluate the association of statin use with thyroid cancer based on a population-based data set. Design The data for this case-control study were sourced from the Taiwan Longitudinal Health Insurance Database 2000. We included 500 subjects with thyroid cancer as cases and 2500 gender- and age-matched subjects without thyroid cancer as controls. We used a conditional logistic regression to calculate the odds ratio (OR) and its corresponding 95% confidence interval (CI) for having previously used statins between cases and controls. Results The OR of prior statin use for cases was 1·39 (95% CI = 1·08-1·78) compared to controls, and thyroid cancer was significantly associated with previous regular statin use (OR = 1·40, 95% CI = 1·05-1·86). However, thyroid cancer was not significantly associated with previous irregular statin use (OR = 1·35; 95% CI = 0·88-2·07). Furthermore, the significant association between thyroid cancer and previous statin use only existed for females (OR: 1·43; 95% CI: 1·07-1·90) but not for males (OR: 1·28; 95% CI: 0·75-2·17). Conclusions We concluded that statin use was associated with thyroid cancer in female patients.

AB - Objective Several observational studies raised the possibility that the use of statins may decrease the overall risk of cancer and of specific cancers. This study aimed to evaluate the association of statin use with thyroid cancer based on a population-based data set. Design The data for this case-control study were sourced from the Taiwan Longitudinal Health Insurance Database 2000. We included 500 subjects with thyroid cancer as cases and 2500 gender- and age-matched subjects without thyroid cancer as controls. We used a conditional logistic regression to calculate the odds ratio (OR) and its corresponding 95% confidence interval (CI) for having previously used statins between cases and controls. Results The OR of prior statin use for cases was 1·39 (95% CI = 1·08-1·78) compared to controls, and thyroid cancer was significantly associated with previous regular statin use (OR = 1·40, 95% CI = 1·05-1·86). However, thyroid cancer was not significantly associated with previous irregular statin use (OR = 1·35; 95% CI = 0·88-2·07). Furthermore, the significant association between thyroid cancer and previous statin use only existed for females (OR: 1·43; 95% CI: 1·07-1·90) but not for males (OR: 1·28; 95% CI: 0·75-2·17). Conclusions We concluded that statin use was associated with thyroid cancer in female patients.

UR - http://www.scopus.com/inward/record.url?scp=84932095774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84932095774&partnerID=8YFLogxK

U2 - 10.1111/cen.12570

DO - 10.1111/cen.12570

M3 - Article

C2 - 25074346

AN - SCOPUS:84932095774

VL - 83

SP - 111

EP - 116

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

IS - 1

ER -